Form 4 for GEHC GE HealthCare
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-01 · accession 0001628280-25-010707 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | GEHC | O'Neill Kevin Michael | CEO, PDx | A - Grant | $0.00 | +4,626 | 23.0K | +25% | $0 |
| D | 2025-03-05 | 2025-03-01 | GEHC | O'Neill Kevin Michael | CEO, PDx | F - Tax | $87.35 | -1,521 | 18.4K | -8% | -$132.9K |
| D | 2025-03-05 | 2025-03-03 | GEHC | O'Neill Kevin Michael | CEO, PDx | A - Grant | $0.00 | +13.2K | 13.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2025-03-03 | A | A | 4,626 | $0.00 | 22,980 | D | — | — | (F2) Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. (F3) Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028. |
| 2 | Common | Common Stock, par value $0.01 per share | 2025-03-01 | F | D | 1,521 | $87.35 | 18,354 | D | — | — | (F1) Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-03-03 | A | A | 13,231 | $0.00 | 13,231 | D | $86.45 · — to 2035-03-03 | 13,231 Common Stock, par value $0.01 per share | (F4) Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. |